4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-002613
Chief Financial Officer sold 20,000 shares at an average $60.11 ($1,202,201)
From the SEC's structured data for this filing
Trades in this filing
Myszkowski Kenneth Allen · Chief Financial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-01-06 | Sale : show line 1 in the form | −7,593 | $59.60 | $452,543 | 403,592 | D |
| 2020-01-06 | Sale : show line 2 in the form | −11,907 | $60.40 | $719,183 | 391,685 | D |
| 2020-01-06 | Sale : show line 3 in the form | −500 | $60.95 | $30,475 | 391,185 | D |
| Open-market sales · 20,000 sh · avg $60.11 · $1,202,201 | ||||||
Loading xslF345X03/doc4.xml…